The global lab on-chip and microarrays market size expected to reach USD 10.2 billion by 2028, growing at a CAGR of 9.4% during forecast period 2022 to 2028. Lab on the chip an evolutionary device which integrates single or many laboratory functions on one integrated circuit commonly, a chip. Lab-on-chip generally measures about few square centimetres and used to achieve automation and high through screening. The microarray is the most recent advances in the cancer research. Microarrays help to analyse plenty of samples which have already been recorded or new samples, it even helps to test the incidence of a particular marker in tutors. There are two types of microarrays, gene expression microarrays and tissue microarrays. The lab on-chip and microarrays market has very few and dominant players who are actively participating in research and development of the new products. Companies are launching the new products to increase the market share. For instance, in November 2016, Abbott laboratories received CE mark for its innovative blood testing device i-STAT Alinity point of care system, a portable device that can perform and analyse largest menu of blood tests on a single device. Furthermore, companies are collaborating in the development of the new products. For instance, in March 2016, CombiMatrix Molecular Diagnostics (CMDX) and Array Genomics Inc. entered into the collaboration agreement to develop and market a series of comparative genomic hybridization (CGH) microarray products.